Immunotherapies can lead to significant adverse effects, particularly immunosuppression, which may elevate the risk of opportunistic infections, as evidenced by studies linking TNF-α inhibitors with increased susceptibility to infections [132]. The gene discussed is TNF; the disease is Opportunistic infection.